Wangshi Baochi Pills alleviate alcoholic liver disease by regulating the gut microbiota composition in a mouse model

• Egile Nagusiak: Song Ye (Egilea), Bin Chen (Egilea), Xinyu Liu (Egilea), Zhengwei Zhang (Egilea), Wenjing Zhao (Egilea), Haoran Wang (Egilea), Lingli Ren (Egilea), Bing Zhao (Egilea), Qian Zhou (Egilea), Xi Chen (Egilea), Yang Yang (Egilea), Peng Cao (Egilea), Juan Ye (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2023-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Introduction: Alcoholic liver disease (ALD) is a leading cause of liver-related morbidity and mortality worldwide. However, there are no currently available drugs for ALD. Wangshi Baochi Pill (WBP) is a is a national confidential formulary of China, commonly used in clinical pediatrics to treat dysp...